Elite PharmaceuticalsELTP 
$0.349.68%24h
9.68%24h
Global rank13752
Market cap$344.39M
Change 7d30.77%
YTD Performance142.86%
SP500 benchmarkOutperform
P/E96.70
P/S10.08
Revenue$34.16M
Earnings$3.56M
Dividend yield-
Main Sector
Healthcare
Elite Pharmaceuticals (ELTP) Net Assets
ELTP Net Assets in 2023: $28.96M
As of 11 Sept 2024, Elite Pharmaceuticals net assets is $28.96M, an increase of 14.82% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Elite Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Elite Pharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
ELTP Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $28.96M | 14.82% |
| 2022 | $25.22M | 56.15% |
| 2021 | $16.15M | 51.58% |
| 2020 | $10.66M | -107.06% |
| 2019 | $-150.98M | - |
View the Top Net Assets Companies
